Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section [NA]

View source ↗

Summary

Clinical trial assessing local subcutaneous gentamicin to prevent surgical site infection after elective cesarean sections; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gentamicin (gentamicin)

Snippet

Sponsor: Western Galilee Hospital-Nahariya | Conditions: Surgical Site Infection | NA | Status: RECRUITING